Coinbase Global heads into the final days of May with the dynamic flagged a week ago now more pronounced: short interest has continued to climb while the stock has reversed, falling 6.8% on the week to $193.45, extending a month in which bulls have lost ground.
Short interest is the clearest signal of where sentiment has shifted. It has risen to 11.7% of the free float — up nearly 3% on the week and 14% over the past month — the highest reading in the current rebuilding cycle. That is roughly 26.7 million shares short, a level that has moved in a near-straight line since early May. The borrow market is not sounding the alarm: cost to borrow remains low at 0.46%, up 23% on the week but still well inside territory that would suggest a crowded or distressed short. Availability is ample at 296% — nearly three shares available to lend for every one currently borrowed — so the short rebuild is a conviction-driven move, not a mechanical squeeze dynamic.
Options tell the same cautious story, but more forcefully. The put/call ratio has climbed to 0.75, now more than two standard deviations above its 20-day average of 0.68. That is the highest defensive reading in a month and is closing in on the 52-week peak of 0.90. A week ago that PCR reading was sitting around 0.70; the additional move this week, combined with the price decline, suggests hedging demand has accelerated rather than faded. Together, the short rebuild and the options skew paint a picture of participants actively positioning against the stock — not simply holding stale hedges.
The Street tells a more divided story. Following the Q1 report earlier this month, analyst targets moved mostly lower: JP Morgan trimmed its target to $283 from $290 while keeping Overweight, Barclays cut to $107 from $140 at Underweight, and several mid-tier names also lowered numbers. The exception was Mizuho, which raised its target to $200 from $170 on May 12, still maintaining a Neutral rating. The mean target sits at $231.61 against a current price of $193.45 — about 20% implied upside — though that average masks a wide dispersion between Barclays' $107 bear case and HC Wainwright's $310 bull case. Bulls point to Coinbase's compliance-focused positioning and institutional growth runway; bears focus on the structural decline in transaction fee revenue and an uncertain regulatory environment. The PE multiple has expanded to 71x over the past month, even as earnings momentum factor scores rank in the bottom decile of the universe, which is a tension the Street has not yet resolved.
Among peers, the week's moves widen that narrative gap. HOOD fell 5.3% in line with COIN. GLXY dropped 12.2% and BLSH lost 15.4%, suggesting the crypto-adjacent complex broadly sold off rather than singling out Coinbase. The exception was BKKT, which rose 9.1% — diverging sharply from the rest of the group. That split makes it harder to read the COIN move as purely idiosyncratic.
The CFO's monthly share sales add a further layer of context. Alesia Haas sold just under 10,000 shares on May 15 at $205.64, the third consecutive monthly sale of roughly the same size and at similar prices. The regularity suggests a pre-scheduled plan rather than an opportunistic exit, but the net insider position over 90 days is actually positive at roughly 222,000 shares — that number is dominated by award or conversion activity rather than open-market buying, so it is worth noting without over-interpreting.
The next earnings event is scheduled for June 16. With short interest at a cycle high, options defensiveness at its most elevated reading in weeks, and the stock now 6% below where it was when the previous note was filed, the question heading into that catalyst is whether the short thesis centres on near-term revenue risks from fee compression or a longer-duration regulatory re-rating — and which camp the June print will satisfy.
See the live data behind this article on ORTEX.
Open COIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
